Discover the detailed record of transactions filed by 최성필, Vice-Président. Officer active across 2 companies, notably 카나프테라퓨틱스. Aggregated, 17,943 filings have been published. History available since 4 March 2026. The latest transaction was filed on 4 March 2026 (Purchase). Regulator: DART (FSS). The full history is accessible without signup.
Choi Sung-pil is the Vice President of 카나프테라퓨틱스, a company specializing in biotechnology. He is involved in product development and operations management. Choi Sung-pil strives to position the company as a leader in innovative therapies.